While several studies have reported a higher prevalence of mutations, particularly BRAF V600E in older patients and their association with more aggressive tumor behavior [28], the relationship between age and mutation status has not been consistently demonstrated across different cohorts. The gene discussed is BRAF; the disease is neoplasm.